APA (7th ed.) Citation

Jayarajan, V., Hall, G. T., Xenakis, T., Bulstrode, N., Moulding, D., Castellano, S., & Di, W. (2023). P09 Short-term rho-associated kinase inhibitor treatment promotes primary keratinocyte growth without affecting keratinocyte stem cell properties. The British journal of dermatology, 189(1), e17. https://doi.org/10.1093/bjd/ljad174.031

Chicago Style (17th ed.) Citation

Jayarajan, Vignesh, George T. Hall, Theodoros Xenakis, Neil Bulstrode, Dale Moulding, Sergi Castellano, and Wei-Li Di. "P09 Short-term Rho-associated Kinase Inhibitor Treatment Promotes Primary Keratinocyte Growth Without Affecting Keratinocyte Stem Cell Properties." The British Journal of Dermatology 189, no. 1 (2023): e17. https://doi.org/10.1093/bjd/ljad174.031.

MLA (9th ed.) Citation

Jayarajan, Vignesh, et al. "P09 Short-term Rho-associated Kinase Inhibitor Treatment Promotes Primary Keratinocyte Growth Without Affecting Keratinocyte Stem Cell Properties." The British Journal of Dermatology, vol. 189, no. 1, 2023, p. e17, https://doi.org/10.1093/bjd/ljad174.031.